0.15 (0.845%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Strong
Earnings
Neutral
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Neutral
Website
NovoCure Ltd.
Telephone
44.15.3475.6700
Address
2nd Floor, Grenville Street, No. 4 The Forum, St. Helier, Jersey JE2 4UF
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 9.82 - 20.06
Trade Value (12mth)
US$5,750,041.00
1 week
0.97%
1 month
36.33%
YTD
35.29%
1 year
-1.99%
All time high
232.76
EPS 3 yr Growth
38.20%
EBITDA Margin
-21.00%
Operating Cashflow
-$49m
Free Cash Flow Return
-9.30%
ROIC
-25.80%
Interest Coverage
-6.20
Quick Ratio
2.70
Shares Outstanding (Fully Diluted)
114m
HALO Sector
Healthcare
Next Company Report Date
25-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 30 April 26 | |
| 30 April 26 | |
| 30 April 26 | |
| 25 April 26 | |
| 25 April 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -1.95 | -1.56 | -1.22 | | | | ||
EPS (Fully Diluted) | $ | | | | | -1.95 | -1.56 | -1.22 | | | | ||
Growth | % | | | | | -120.1 | 19.6 | 21.9 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
